Under certain circumstances cytotoxic T lymphocytes (CTL) 1 are induced by processed antigen (1, 2). The mechanism of processing is still unknown, but macrophage-like accessory cells (AC) are involved (3-6). The processing presumably allows small particles of antigen to form an immunogenic association with gene products coded for by the major histocompatibility complex (MHC).
Generation of CTL In Vitro.
In all experiments, except those described in Table I where unmanipulated TDL were used, TDL were washed, counted, and incubated on nylon wool columns. The nonadherent population was harvested and cultured at 10 7 responder to 10 6 tumor stimulator per 20 ml of Iscove's medium or 107 responder to 2 × 107 lymph node stimulator cells. Tumors received 5,000 and lymph nodes 2,000 rad of x irradiation (RT 305, 300 kV, 10 mA; Phillips X-Ray, Phillips, Holland) before their use as stimulators. To some cultures 5% G-100 column purified concanavalin A supernatant factor (Con A SnF) from rat spleen cell cultures was added (22) . Cultures were incubated for 6 d at 37°C in a humidified atmosphere containing 5% CO2, in Coming 25100 tissue culture flasks (Corning Glass Works, Coming, NY).
Cytotoxicity Assay. After 6 d, which was found to be optimal, cultures were washed twice, the cells resuspended in RPMI 1640 and added, at various dilutions in 0.1 ml vol, to Greiner 96 well v-bottomed microtiter plates together with 5 X 103 ~lchromium-labeled tumor targets or Con A blasts. The latter were prepared by incubating lymph node cells at a final concentration of 2 × 106/ml in Iscove's medium containing 5 btg/ml Con A for 2-3 d. Plates were incubated at 37°C in a humidified atmosphere containing 5% COz for 4 b, centrifuged, and 50% of the volume was harvested and counted. Values reported are the mean specific release of triplicates, provided the standard error did not exceed 10% and the specific release was >10%.
Negative Selection on Adoptive Transfer. HL/AS F1 rats were sublethally irradiated (600 rad), cannulated within 3 d after irradiation, and injected intravenously with 3-10 × 109 parental (AS) TDL. Because the modal transit time from blood to lymph for T ceils is shorter than for B cells (23) , the population collected 6-24 h after injection is virtually all T cells (24) of donor origin. During the 6-24-h selection period all anti-host reactive T ceils remain sequestered in the irradiated F1 host lymphoid tissue (25) . The selected TDL are unreactive to host alloantigens in mixed lymphocyte and local graft-vs.-host responses and normal for third-party alloantigens (26) , Negative Selection In Situ. Normal rats were injected intravenously with 20-100 X 106 HL-A2T2 (over this range no differences in response were observed), or 400 X 106 irradiated AS/ HL lymph node and spleen cells. These animals were cannulated 24 h later and TDL collected for 1 d.
In some experiments tumor-injected rats were placed in a restraining cage and infused through a tail vein over a 24-h period with Con A SnF containing saline. An equivalent of roughly four spleen donors was injected per rat during this time. Control rats received Con A SnF in the absence of tumor antigen.
Results
Experimental Approach. AS and HL are two strains of rats which differ at the MHC (RT1). In the presence of Con A SnF, normal HL thoracic duct lymphocytes cultured in vitro with HL-A2T2 cells, an adenovirus-transformed line of HL origin, give high T cell-mediated (27) primary CTL responses directed to the tumor-specific antigens on HL-A2T2 ceils (unpublished data). These CTL also give high tysis on other HLderived adenovirus-transformed lines, e.g., HL-B1, but only low lysis on MHCdifferent AS adenovirus-transformed cells, e.g., AS-F-4 (Materials and Methods). These data suggest that the response to the tumor-specific antigens on the transformed cells is probably MHC-restricted, although definitive evidence on this point has yet to be obtained.
The experiments considered below were designed to determine whether CTLp for HL-A2T2 tumor ceils exist in an MHC-different strain, i.e., in normal AS rats. Addressing this question necessitates depleting the responding AS lymphocytes of alloreactivity to HL MHC determinants. The procedure used here was to filter AS TDL from blood to lymph for 1 d through irradiated HL/AS F1 rats (Materials and Methods). In this system donor cells with alloreactivity to the host are sequestered in the spleen and fail to enter the central lymph; recirculation of donor T cells with other specificities is unimpeded. It should be mentioned that B cells recirculate poorly in irradiated rats, and the lymph-borne cells consist almost entirely of donor-derived T cells (24) .
In addition to the above system, some of the experiments considered below employed a different system in which negative selection was induced in situ, i.e., in the donor rat itself. This procedure involves injecting rats with large doses of irradiated allogeneic cells and then collecting the host-derived cells from the central lymph 1 day later (Materials and Methods). As in the adoptive transfer selection system described above, the responding T cells become selectively sequestered in the spleen and are absent from TDL. By injecting tumor ceils rather than lymphoid cells this system can be used to study negative selection of cells involved in tumor-specific CTL.
Recognition of Tumor Antigens by MHC-different T Cells. As shown in Table I , unprimed AS TDL incubated for 6 d in vitro with irradiated MHC-different HL-A2T2 tumor cells give high lysis on HL-A2T2 and HL-B1 targets and only low lysis on syngeneic AS-F-4 targets (column 1). High lysis is also observed against HL Con A blasts, which implies that some of the lysis against the HL-derived tumors is presumably directed against HL MHC alloantigens. Evidence that the HL tumors do indeed express HL MHC determinants comes from the fact that the tumors are lysed by AS TDL stimulated with normal HL lymph node cells (column 2).
Filtration of AS TDL from blood to lymph through irradiated AS/HL Fa rats removes alloreactivity to HL, When these AS-nL TDL are cultured with HL-A2T2 cells, no lysis is observed on HL Con A blasts (Table I, In assessing the significance of these findings it was conceivable that the CTL activity derived from the AS.nL-fihered T cells (Table I , column 3) reflected the presence of accessory cells. On a priori grounds these cells could have been derived either from the donor cells or from the irradiated F1 selection host; in either situation the accessory cells would be at least semisyngeneic with respect to the responding T cells.
TABLE I

Generation of Killer Cells against HL Strain Tumors in tile Absence of T Cells Specific for HL Alloantigens
Tarot Column: Responder:
Stimulator: E/T*: Normal AS and AS-HL TDL were collected as described in Materials and Methods. The nylon wool nonadherent fractions were cultured with irradiated HL-A2T2 tumor. ACAs, ACnL = 2,000 rad-irradiated AS or HL lymph node ceils.
To examine this question, the lymph-borne AS-nL TDL were passed through nylon wool columns and then stimulated with HL-A2T2 tumor cells, with or without exogenous accessory cells. T cells purified from normal AS TDL were used as a control. As shown in Table II Selective Sequestration of TH Cells and CTLp. The above findings corroborate the well-established finding that TH cells (or products in Con A SnF) control CTL generation in vitro. Depending on the conditions used, help presumably reflects interleukin production resulting from T cell contact with either (a) MHC alloantigens (alloreactive AS T cells confronting HL accessory cells; Table II , column 1) or (b) tumor antigens presented on accessory cells. In the case of CTL generated from AS-He T cells, the simplest explanation for the requirement for syngeneic accessory cells is that help reflects MHC-restricted recognition of processed tumor antigens. Tumorspecific TH cells recognize degraded antigen on accessory cells, but only when the latter are MHC compatible.
To seek further information on the role of tumor-specific TH cells, TDL were taken from AS rats given HL-A2T2 tumor cells intravenously 1 d before. Based on the findings of other workers (28, 29) , the expectation here was that accessory cells of the host would process the injected tumor cells and thereby lead to negative selection of tumor-specific TH ceils. If CTLp were not selected under these conditions (the above references did not address this point directly), TDL from these rats would contain only tumor-specific CTLp and not TH cells.
The experiment shown in Table III , column 3 suggests that injecting the TDL donors 1 d previously with HL-A2T2 tumor cells does indeed remove tumor-specific TH cells but not CTLp. When TDL from these rats are filtered through AS/HL Fx rats to remove alloreactivity and then through nylon wool columns to remove accessory cells, the T cells fail to generate anti-tumor CTL in vitro in the presence of either syngeneic or allogeneic accessory cells. By contrast, addition of Con A SnF during culture generates high CTL activity. When TDL from the tumor-injected rats are not filtered through AS/HL F1 rats before culture, the addition of allogeneic accessory cells restores CTL activity (Table III , column 1); syngeneic accessory cells give no response. The effect observed with the allogeneic accessory cells presumably reflects a response (interleukin production) to HL alloantigens. In this respect, culturing the TDL with HL lymph node cells generates appreciable CTL activity on HL Con A blasts (column 2). Collectively, the results in Table III suggest that preinjecting the TDL donors selectively removes only tumor-specific Tn cells. There is little or no removal of tumorspecific CTLp, even if fivefold higher doses of tumor cells are injected (data not shown). There is also no apparent removal of either Tn or CTLp reactive to HL alloantigens.
The failure to deplete alloreactivity by injecting tumor cells might be a reflection of the fact that the HL-A2T2 tumor lacks class II (Ia) molecules (30) plus LN cells (50% Ia +) 1 d before (Table IV) . When nylon-wool-passed TDL from these rats are cultured with HL lymph node cells in vitro, no CTL for HL Con A blasts are generated even in the presence of Con A SnF (column 1). The TDL thus lacked allospecific CTLp. When the TDL are cultured with HL-A2T2 tumor cells, anti-tumor CTL activity is generated, but only in the presence of syngeneic and not allogeneic accessory cells. This latter finding implies that the TDL lacked allospecific T~ cells (cells able to provide nonspecific help in response to HL alloantigens). These data are summarized in Table V . With respect to anti-tumor CTL, it is to be noted that addition of syngeneic accessory cells does restore the capacity of TDL from F1 spleen-injected AS rats to generate CTL to HL-A2T2 cells (Table IV, column 2) . This is the same result observed in Table II, when HL-A2T2 tumor cells are injected into MHC-compatible HL rats.
The experiment shown in Fig. 2 was designed to examine the notion that CTLp in vivo may recognize tumor antigens (receive signal 1) but are not selected (sequestered) because they fail to receive a second signal. To test this prediction AS rats were injected with tumor ceils and then perfused with Con A SnF, a presumed source of the second signal. Control rats were untreated, treated with tumor alone, or treated with Con A SnF alone. The results (Fig. 2) show a pronounced reduction in anti-HL A2T2 tumor (Fig. 2 a) and anti-HL (Fig. 2 b) activity in the group that received both tumor cells and Con A SnF. The control groups, given tumor or Con A SnF alone, did not differ from the untreated controls. The four groups showed equivalent reactivity against a third party alloantigen (Fig. 2c) , indicating that retention of CTLp was specific for the injected antigen. A single experiment with concomitant injection of HL lymphoid and tumor cells revealed that tumor specific CTLp were not retained unless Con A SnF was also supplied.
Discussion
The results in this paper demonstrate that, in the absence of alloreactivity, activation of killer ceils against allogeneic tumor antigens in vitro requires the cooperation of tumor-specific helper T ceils. Stimulation of the helper ceils requires syngeneic accessory cells; these cells presumably "process" the tumor antigens and present them in association with self MHC determinants. Recognition of processed antigen is important only for TH cells and not CTLp. Once the helper cell-accessory cell interaction has taken place, a variety of soluble factors is released and these are sufficient to induce the CTLp-CTL transition.
According to the above scheme, the activation and differentiation of CTLp requires two signals: (a) recognition of antigen on the tumor cells by CTLp and (b) a signal provided by TH cells. Whether these signals must be received simultaneously is difficult to study in vitro since CTL are measured only after a period of 6 d. A key question is whether CTLp can recognize antigen in the absence of the second signal. A useful approach to this question is to examine the requirements for producing negative selection ofT cells in vivo--a phenomenon that occurs within 1 d of contact with antigen. Since negative selection is manifested by a withdrawal of T cells from the recirculating lymphocyte pool, one might conclude that selection is simply a reflection of antigen binding by the responding T cells. If this were the case, the selection of CTLp would require only one signal. Alternatively, selection of CTLp might reflect T cell activation and thus require a second signal.
The experiments in this paper suggest that selection of CTLp does indeed require two signals. Little or no selection of either tumor-specific or allospecific CTLp occurs when the T cells are exposed to these antigens on tumor cells in vivo in the absence of Con A SnF. In the presence of Con A SnF, by contrast, effective selection occurs. In interpreting these findings two points should be emphasized. First, the precise effects of Con A SnF in promoting negative selection of CTLp are not clear. Con A SnF is known to contain a variety of lymphokines, including interleukins 1 and 2 (9) and a cytotoxic T lymphocyte differentiation factor (10) . Any or all of these factors might control negative selection. Secondly, in contrast to tumor cells, injection of allogeneic lymphoid cells does select allospecific CTLp in the absence of Con A SnF (Table IV) . Although this requirement for Ia + cells as the targets for negative selection has yet to be proved, one could envisage that these cells simultaneously attract both TH cells and CTLp, with the result that the CTLp are exposed to a high local concentration of helper factors (signal 2). Alternatively, the Ia + cells themselves might release factors which facilitate recognition of antigen by the CTLp.
The model of CTL activation developed in this study fits also several observations that were difficult to reconcile with data provided by in vitro experiments. Zinkernagel et al. (31) and yon Boehmer and Haas (32) demonstrated a requirement for I region sharing in the generation of CTL in vivo. Keene and Forman (33) showed that for effective priming to occur in vivo helper determinants required for expression of CTL activity must be on the same cell as the CTL determinants. Korngold and Sprent (34) reported that the induction of graft-vs.-host disease requires contact with antigen on marrow-derived (AC?) cells, whereas the effector cells were targeted to Ia negative non-marrow-derived cells. In each case the immunogenicity of a target antigen for a K,D-restricted CTL would appear to controlled by the I region. These data are in apparent disagreement with a study of Doherty and Bennink (35) , who concluded that virus-specific CTL can be activated to antigen in Ia-incompatible irradiated mice. These authors used an in vivo filtration system to remove alloreactive T cells but did not attempt to remove accessory cells from the filtered T cell population. Hence carry-over of accessory cells might explain their results (Table II and reference 36) .
Finally, comment should be made on the following paradox. It was mentioned earlier (Results) that primary responses to syngeneic adenovirus-transformed tumors are low unless the cultures are supplemented with Con A SnF. This finding implies that unprimed rats are relatively deficient in tumor-specific T~ cells. In allogeneic situations, by contrast, high primary antitumor responses are observed in the absence of Con A SnF (Table II) ; the response occurs in the apparent absence of alloreactive T cells and requires syngeneic accessory cells. In the light of this finding, one reaches the surprising conclusion that the precursor frequency of tumor-specific TH cells is much higher when the antigens are derived from MHC-incompatible tumor cells. Possible explanations for this unexpected finding are discussed elsewherefl Summary Strain AS rats respond with two populations of cytotoxic T lymphocytes to stimulation in vitro by the major histocompatibility complex (MHC)-incompatible strain HL rat tumor (HL-A2T2). One is specific for MHC alloantigens present on both HL-A2T2 and normal HL targets, the other is tumor specific. The activation of these killer cells requires helper T lymphocytes. The tumor-specific helper cells depend on syngeneic radioresistant accessory cells to present the tumor antigens in an immunogenic form. The appropriate helper-accessory cell interaction results in the production of soluble factors which then induce the maturation of precursor cells into effective killer cells.
Studies with a procedure for inducing negative selection of T cells in vivo showed that short-term exposure to HL-A2T2 tumor induced selection only of TH but not cytotoxic T lymphocyte precursors (CTLp). Simultaneous injection of supernatants from concanavalin A-activated spleen cell cultures, however, did produce selection of CTLp. These and other findings suggest that under normal circumstances in vivo, both signals (recognition of antigen and acceptance of maturation factors) are provided in the vicinity of an antigen presenting macrophage-like accessory cell.
